KRYS Key Financial Ratios - Krystal Biotech, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	8.32	—	16.09%	17.77%
2026-03-31	9.46	—	16.11%	17.63%
2025-12-31	9.95	—	15.36%	16.80%
2025-09-30	10.14	—	16.04%	17.48%
2025-06-30	9.68	—	12.89%	14.10%
2025-03-31	9.65	—	11.54%	12.59%
2024-12-31	7.28	—	8.44%	9.42%
2024-09-30	7.97	—	5.33%	5.91%
2024-06-30	9.5	—	11.54%	12.63%
2024-03-31	12.66	—	6.70%	7.15%
2023-12-31	17.76	—	1.34%	1.40%
2023-09-30	21.1	—	-3.77%	-3.94%
2023-06-30	20.25	—	-20.53%	-21.50%
2023-03-31	10.13	—	-25.44%	-27.64%
2022-12-31	13.3	—	-25.06%	-26.80%
2022-09-30	14.18	—	-22.51%	-23.99%
2022-06-30	12.45	—	-19.20%	-20.65%
2022-03-31	7.25	—	-16.81%	-18.91%
2021-12-31	17.18	—	-11.11%	-11.72%
2021-09-30	9.67	—	-12.89%	-14.24%
2021-06-30	20.42	—	-11.76%	-12.46%
2021-03-31	44.38	—	-9.62%	-9.90%
2020-12-31	17.8	—	-10.35%	-11.01%
2020-09-30	39.96	—	-8.71%	-9.00%
2020-06-30	51.2	—	-6.85%	-7.04%
2020-03-31	46.38	—	-9.90%	-10.24%
2019-12-31	58.88	—	-9.13%	-9.41%
2019-09-30	54.87	—	-8.14%	-8.40%
2019-06-30	49.8	—	-7.76%	-8.03%
2019-03-31	33.28	—	-11.11%	-11.74%
2018-12-31	43.39	—	-9.38%	-9.62%
2018-09-30	27.57	—	-15.75%	-16.40%
2018-06-30	60.22	—	-24.10%	-24.50%
2018-03-31	105.46	—	-20.01%	-20.20%
2017-12-31	77.99	—	-15.80%	-16.01%
2017-09-30	21.26	—	-13.58%	-14.25%
2016-12-31	50.44	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	9.95	—	15.36%	16.80%
2024-12-31	7.28	—	8.44%	9.42%
2023-12-31	17.76	—	1.34%	1.40%
2022-12-31	13.3	—	-25.06%	-26.80%
2021-12-31	17.18	—	-11.11%	-11.72%
2020-12-31	17.8	—	-10.35%	-11.01%
2019-12-31	58.88	—	-9.13%	-9.41%
2018-12-31	43.39	—	-9.38%	-9.62%
2017-12-31	77.99	—	-15.80%	-16.01%
2016-12-31	50.44	—	-52.70%	-397.92%